Professor Mark Kendall’s, from Bio engineering and Nanotechnology team, has been credited with developing a Nanopatch which uses 100 times lesser vaccine than a syringe and also of a size of postal stamp.
The Nanopatch will prove very helpful to the nations that face shortage of vaccination and can also modernize the vaccination programs both in industrialized and developing nations.
Prof Kendall explained that Nanopatch focuses on specific antigen-presenting cells that are found beneath the skin surface; this in turn less than one-hundredth of the dose used by a needle was used to force the intended immune response.
It is noticeable that this research claims their finding to be 10 times better than any other methods. Another plus point is that the nanopatch does not even require any immune stimulants or adjuvants, not even any multiple vaccinations.
The discovery although is minute in size, but is capable of encompassing thousands of densely packed projections that cannot be seen by a human eye